

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 6.71720248 |
| 2 | doxorubicin metabolic process (GO:0044598) | 6.71720248 |
| 3 | daunorubicin metabolic process (GO:0044597) | 6.71720248 |
| 4 | heterochromatin organization (GO:0070828) | 5.68097127 |
| 5 | protein localization to kinetochore (GO:0034501) | 5.62990522 |
| 6 | negative regulation of epidermis development (GO:0045683) | 5.03958786 |
| 7 | muscle organ morphogenesis (GO:0048644) | 4.93667764 |
| 8 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.92508216 |
| 9 | maintenance of protein location in nucleus (GO:0051457) | 4.92457886 |
| 10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.91567160 |
| 11 | pre-miRNA processing (GO:0031054) | 4.88736667 |
| 12 | histone H4-K12 acetylation (GO:0043983) | 4.85997088 |
| 13 | nuclear pore complex assembly (GO:0051292) | 4.74551894 |
| 14 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.74170463 |
| 15 | regulation of gene silencing by RNA (GO:0060966) | 4.71920911 |
| 16 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.71920911 |
| 17 | regulation of gene silencing by miRNA (GO:0060964) | 4.71920911 |
| 18 | histone H4-K5 acetylation (GO:0043981) | 4.71877436 |
| 19 | histone H4-K8 acetylation (GO:0043982) | 4.71877436 |
| 20 | Golgi transport vesicle coating (GO:0048200) | 4.60945181 |
| 21 | COPI coating of Golgi vesicle (GO:0048205) | 4.60945181 |
| 22 | regulation of hippo signaling (GO:0035330) | 4.53630362 |
| 23 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.49416575 |
| 24 | somite rostral/caudal axis specification (GO:0032525) | 4.43481457 |
| 25 | chromatin assembly (GO:0031497) | 4.39609897 |
| 26 | negative regulation of telomerase activity (GO:0051974) | 4.36006880 |
| 27 | nuclear pore organization (GO:0006999) | 4.31938418 |
| 28 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.31570765 |
| 29 | protein localization to endosome (GO:0036010) | 4.29824506 |
| 30 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.27841535 |
| 31 | maternal placenta development (GO:0001893) | 4.26659008 |
| 32 | regulation of response to osmotic stress (GO:0047484) | 4.25764089 |
| 33 | notochord development (GO:0030903) | 4.24270725 |
| 34 | mitotic sister chromatid segregation (GO:0000070) | 4.15008757 |
| 35 | intestinal epithelial cell development (GO:0060576) | 4.06267400 |
| 36 | RNA stabilization (GO:0043489) | 4.03292739 |
| 37 | mRNA stabilization (GO:0048255) | 4.03292739 |
| 38 | trophectodermal cell differentiation (GO:0001829) | 3.95716078 |
| 39 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.95346754 |
| 40 | protein localization to chromosome, centromeric region (GO:0071459) | 3.95250912 |
| 41 | positive regulation of histone deacetylation (GO:0031065) | 3.93832239 |
| 42 | rRNA transcription (GO:0009303) | 3.93305704 |
| 43 | hormone catabolic process (GO:0042447) | 3.88258484 |
| 44 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.84977088 |
| 45 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.83308137 |
| 46 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.83308137 |
| 47 | NLS-bearing protein import into nucleus (GO:0006607) | 3.82360132 |
| 48 | skin morphogenesis (GO:0043589) | 3.80225698 |
| 49 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.75617458 |
| 50 | sister chromatid segregation (GO:0000819) | 3.71059413 |
| 51 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.67189153 |
| 52 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.63980205 |
| 53 | histone H4-K16 acetylation (GO:0043984) | 3.62167080 |
| 54 | positive regulation of protein deacetylation (GO:0090312) | 3.61784981 |
| 55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.56829535 |
| 56 | polarized epithelial cell differentiation (GO:0030859) | 3.52770421 |
| 57 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.52529378 |
| 58 | barbed-end actin filament capping (GO:0051016) | 3.50727393 |
| 59 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.48546637 |
| 60 | regulation of translation in response to stress (GO:0043555) | 3.45299791 |
| 61 | regulation of early endosome to late endosome transport (GO:2000641) | 3.42474130 |
| 62 | pinocytosis (GO:0006907) | 3.42028872 |
| 63 | cell adhesion mediated by integrin (GO:0033627) | 3.39649234 |
| 64 | pore complex assembly (GO:0046931) | 3.36051677 |
| 65 | cytidine deamination (GO:0009972) | 3.32226666 |
| 66 | cytidine metabolic process (GO:0046087) | 3.32226666 |
| 67 | cytidine catabolic process (GO:0006216) | 3.32226666 |
| 68 | primitive streak formation (GO:0090009) | 3.32199221 |
| 69 | hypotonic response (GO:0006971) | 3.31756318 |
| 70 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.29117207 |
| 71 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.28220275 |
| 72 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.26888507 |
| 73 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.23191913 |
| 74 | stress fiber assembly (GO:0043149) | 3.20240335 |
| 75 | maintenance of protein localization in organelle (GO:0072595) | 3.18419824 |
| 76 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.18340173 |
| 77 | epoxygenase P450 pathway (GO:0019373) | 3.17392698 |
| 78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16929106 |
| 79 | adherens junction assembly (GO:0034333) | 3.14357170 |
| 80 | focal adhesion assembly (GO:0048041) | 3.13361665 |
| 81 | cell-substrate adherens junction assembly (GO:0007045) | 3.13361665 |
| 82 | phenol-containing compound catabolic process (GO:0019336) | 3.12422693 |
| 83 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.12197233 |
| 84 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.11733791 |
| 85 | cell-substrate junction assembly (GO:0007044) | 3.09661280 |
| 86 | protein retention in ER lumen (GO:0006621) | 3.08050009 |
| 87 | negative regulation of cell size (GO:0045792) | 3.06895021 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.06445770 |
| 89 | establishment of apical/basal cell polarity (GO:0035089) | 3.01554334 |
| 90 | nodal signaling pathway (GO:0038092) | 3.01502855 |
| 91 | mitotic chromosome condensation (GO:0007076) | 3.00815910 |
| 92 | formation of translation preinitiation complex (GO:0001731) | 2.97923961 |
| 93 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.97858335 |
| 94 | epithelial cell-cell adhesion (GO:0090136) | 2.97081370 |
| 95 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96956444 |
| 96 | desmosome organization (GO:0002934) | 2.91309371 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.90684965 |
| 98 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.90425728 |
| 99 | proline transport (GO:0015824) | 2.90332719 |
| 100 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.89960908 |
| 101 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.89366409 |
| 102 | DNA duplex unwinding (GO:0032508) | 2.87084370 |
| 103 | modulation by symbiont of host cellular process (GO:0044068) | 2.86676162 |
| 104 | cellular senescence (GO:0090398) | 2.86287962 |
| 105 | negative regulation of viral release from host cell (GO:1902187) | 2.85510431 |
| 106 | regulation of vitamin metabolic process (GO:0030656) | 2.85168029 |
| 107 | anterior/posterior axis specification, embryo (GO:0008595) | 2.85132205 |
| 108 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84635251 |
| 109 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.84166244 |
| 110 | retinoic acid receptor signaling pathway (GO:0048384) | 2.83883323 |
| 111 | cell migration involved in gastrulation (GO:0042074) | 2.83357937 |
| 112 | activation of Rac GTPase activity (GO:0032863) | 2.83317145 |
| 113 | DNA geometric change (GO:0032392) | 2.83251192 |
| 114 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.83064736 |
| 115 | vitamin A metabolic process (GO:0006776) | 2.82642444 |
| 116 | positive regulation of extracellular matrix organization (GO:1903055) | 2.82214081 |
| 117 | hemidesmosome assembly (GO:0031581) | 2.78546099 |
| 118 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.78262077 |
| 119 | embryonic placenta development (GO:0001892) | 2.78247477 |
| 120 | bone trabecula formation (GO:0060346) | 2.78238934 |
| 121 | establishment of endothelial barrier (GO:0061028) | 2.77945424 |
| 122 | mannose metabolic process (GO:0006013) | 2.76138317 |
| 123 | cellular response to osmotic stress (GO:0071470) | 2.74277404 |
| 124 | apoptotic cell clearance (GO:0043277) | 2.73338281 |
| 125 | negative regulation of gene silencing (GO:0060969) | 2.73033660 |
| 126 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.72652147 |
| 127 | basement membrane organization (GO:0071711) | 2.71779644 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71180152 |
| 129 | embryonic process involved in female pregnancy (GO:0060136) | 2.70660111 |
| 130 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.70166524 |
| 131 | response to laminar fluid shear stress (GO:0034616) | 2.70075040 |
| 132 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68714517 |
| 133 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.68375276 |
| 134 | interferon-gamma secretion (GO:0072643) | 2.65993181 |
| 135 | cardiovascular system development (GO:0072358) | 2.65589536 |
| 136 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.64106372 |
| 137 | DNA unwinding involved in DNA replication (GO:0006268) | 2.63781311 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.63751630 |
| 139 | response to dietary excess (GO:0002021) | 2.63681704 |
| 140 | negative regulation of glial cell proliferation (GO:0060253) | 2.63312030 |
| 141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63299839 |
| 142 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.62719113 |
| 143 | DNA replication checkpoint (GO:0000076) | 2.61727832 |
| 144 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.59988847 |
| 145 | interferon-gamma production (GO:0032609) | 2.59789666 |
| 146 | regulation of extracellular matrix disassembly (GO:0010715) | 2.59280530 |
| 147 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.59035205 |
| 148 | substrate-dependent cell migration (GO:0006929) | 2.56862926 |
| 149 | positive regulation of nuclease activity (GO:0032075) | 2.55202968 |
| 150 | regulation of histone H3-K27 methylation (GO:0061085) | 2.54962641 |
| 151 | cellular response to virus (GO:0098586) | 2.53532425 |
| 152 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.53200599 |
| 153 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52872820 |
| 154 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.51019459 |
| 155 | activation of MAPKKK activity (GO:0000185) | 2.49108672 |
| 156 | regulation of integrin activation (GO:0033623) | 2.47874802 |
| 157 | ER-nucleus signaling pathway (GO:0006984) | 2.47748858 |
| 158 | adhesion of symbiont to host (GO:0044406) | 2.46553480 |
| 159 | mammary gland epithelial cell proliferation (GO:0033598) | 2.43290764 |
| 160 | endocytic recycling (GO:0032456) | 2.42589163 |
| 161 | response to peptidoglycan (GO:0032494) | 2.41231767 |
| 162 | hyaluronan catabolic process (GO:0030214) | 2.41052841 |
| 163 | embryo implantation (GO:0007566) | 2.40044408 |
| 164 | vesicle coating (GO:0006901) | 2.38467965 |
| 165 | membrane protein ectodomain proteolysis (GO:0006509) | 2.38269388 |
| 166 | decidualization (GO:0046697) | 2.38026187 |
| 167 | peptidyl-proline hydroxylation (GO:0019511) | 2.37418707 |
| 168 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.37298365 |
| 169 | regulation of nuclease activity (GO:0032069) | 2.37218214 |
| 170 | glycosphingolipid catabolic process (GO:0046479) | 2.36876870 |
| 171 | response to type I interferon (GO:0034340) | 2.34562210 |
| 172 | response to vitamin D (GO:0033280) | 2.34515459 |
| 173 | proline biosynthetic process (GO:0006561) | 2.33681939 |
| 174 | cellular response to interferon-alpha (GO:0035457) | 2.33219283 |
| 175 | cellular response to type I interferon (GO:0071357) | 2.33090051 |
| 176 | type I interferon signaling pathway (GO:0060337) | 2.33090051 |
| 177 | virion attachment to host cell (GO:0019062) | 2.32381131 |
| 178 | adhesion of symbiont to host cell (GO:0044650) | 2.32381131 |
| 179 | cellular response to unfolded protein (GO:0034620) | 2.30938108 |
| 180 | COPII vesicle coating (GO:0048208) | 2.29903048 |
| 181 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.29765079 |
| 182 | protein hydroxylation (GO:0018126) | 2.27421000 |
| 183 | endothelial cell chemotaxis (GO:0035767) | 2.27401793 |
| 184 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.26469050 |
| 185 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26326034 |
| 186 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.26263139 |
| 187 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.26117634 |
| 188 | endodermal cell differentiation (GO:0035987) | 2.25248148 |
| 189 | regulation of podosome assembly (GO:0071801) | 2.24410085 |
| 190 | regulation of viral release from host cell (GO:1902186) | 2.24171714 |
| 191 | myeloid dendritic cell differentiation (GO:0043011) | 2.21221509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.16154097 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.16154097 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.16154097 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63333476 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.55349188 |
| 6 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.86240826 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70371334 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.63999653 |
| 9 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.58913108 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.54110649 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51555448 |
| 12 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.50107058 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.46964235 |
| 14 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.45554009 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.43197505 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.39794656 |
| 17 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.33835045 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.30819880 |
| 19 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.25051991 |
| 20 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.25020796 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.23683957 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16130862 |
| 23 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.13787454 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12052845 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.07768065 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.05933909 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04887890 |
| 28 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.04287724 |
| 29 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.97457879 |
| 30 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96431469 |
| 31 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.91784414 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.90720318 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89629272 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.87919140 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.86392728 |
| 36 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.86108042 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80346512 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78001654 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73735107 |
| 40 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.65961657 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61017825 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.59924047 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57524944 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56116167 |
| 45 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.54819118 |
| 46 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53548959 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52273022 |
| 48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51305213 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50792379 |
| 50 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.47810833 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45308401 |
| 52 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45096464 |
| 53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44109416 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43289514 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41966447 |
| 56 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.40654851 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39560993 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37564661 |
| 59 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.36745721 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36012671 |
| 61 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.34405199 |
| 62 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.33682766 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33219088 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32466419 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32326967 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31674208 |
| 67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30860970 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30831482 |
| 69 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.30186763 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29396171 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29352986 |
| 72 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29348960 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.28343257 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28067156 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28067156 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27955176 |
| 77 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.27303833 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27097737 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26902802 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25361145 |
| 81 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25333571 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23953611 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21627790 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21394394 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21142979 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19468850 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19238767 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18583096 |
| 89 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17247432 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17097770 |
| 91 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.16794854 |
| 92 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.16315443 |
| 93 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.15285778 |
| 94 | * MAF_26560356_Chip-Seq_TH1_Human | 1.14961205 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14837803 |
| 96 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.13840203 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13417187 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12792912 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11477550 |
| 100 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.11438085 |
| 101 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11284234 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10928312 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10593942 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10291626 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09613513 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09590124 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09442703 |
| 108 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08928830 |
| 109 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08287334 |
| 110 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07607728 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05643183 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05528330 |
| 113 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04671701 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03746568 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02770590 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02735027 |
| 117 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02573186 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02098714 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01086730 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00387899 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99030071 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99014538 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98601165 |
| 124 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98321561 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98057594 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97194797 |
| 127 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.97016821 |
| 128 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96078107 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95960192 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95370057 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95358217 |
| 132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94857051 |
| 133 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93974207 |
| 134 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.93255514 |
| 135 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93072788 |
| 136 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92723871 |
| 137 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91600203 |
| 138 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90696146 |
| 139 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89787828 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89377844 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87952850 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87657711 |
| 143 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.86611284 |
| 144 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85541507 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85310211 |
| 146 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85304882 |
| 147 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.85182685 |
| 148 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84395062 |
| 149 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.82295579 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82084616 |
| 151 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81827049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.83347369 |
| 2 | MP0002254_reproductive_system_inflammat | 4.14109505 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.89148265 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 3.49242969 |
| 5 | MP0004858_abnormal_nervous_system | 3.33346491 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.82309167 |
| 7 | MP0003011_delayed_dark_adaptation | 2.75699575 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 2.68184150 |
| 9 | MP0005451_abnormal_body_composition | 2.62090509 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.50992262 |
| 11 | MP0003303_peritoneal_inflammation | 2.43345388 |
| 12 | MP0003283_abnormal_digestive_organ | 2.36981379 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.36406101 |
| 14 | MP0001849_ear_inflammation | 2.33338146 |
| 15 | MP0009840_abnormal_foam_cell | 2.27193173 |
| 16 | MP0003122_maternal_imprinting | 2.16714601 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.12229923 |
| 18 | MP0003123_paternal_imprinting | 2.04704675 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.96499890 |
| 20 | MP0005380_embryogenesis_phenotype | 1.92398484 |
| 21 | MP0001672_abnormal_embryogenesis/_devel | 1.92398484 |
| 22 | MP0005499_abnormal_olfactory_system | 1.90798644 |
| 23 | MP0005394_taste/olfaction_phenotype | 1.90798644 |
| 24 | MP0004510_myositis | 1.90664181 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.88372582 |
| 26 | MP0003436_decreased_susceptibility_to | 1.88000763 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.87075245 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.86273840 |
| 29 | MP0002088_abnormal_embryonic_growth/wei | 1.86233054 |
| 30 | MP0003984_embryonic_growth_retardation | 1.83579870 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.79574690 |
| 32 | MP0003121_genomic_imprinting | 1.75160568 |
| 33 | MP0002086_abnormal_extraembryonic_tissu | 1.73891530 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.69618806 |
| 35 | MP0004947_skin_inflammation | 1.68706637 |
| 36 | MP0000350_abnormal_cell_proliferation | 1.64063045 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.63210738 |
| 38 | MP0005409_darkened_coat_color | 1.59559870 |
| 39 | MP0004197_abnormal_fetal_growth/weight/ | 1.56528960 |
| 40 | MP0002084_abnormal_developmental_patter | 1.56321846 |
| 41 | MP0003941_abnormal_skin_development | 1.56306025 |
| 42 | MP0008057_abnormal_DNA_replication | 1.55749385 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.55589150 |
| 44 | MP0003279_aneurysm | 1.55386874 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.53334672 |
| 46 | MP0004233_abnormal_muscle_weight | 1.47034706 |
| 47 | MP0005023_abnormal_wound_healing | 1.45522219 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.43456686 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.43345061 |
| 50 | MP0008260_abnormal_autophagy | 1.42101362 |
| 51 | MP0002060_abnormal_skin_morphology | 1.38797721 |
| 52 | MP0001730_embryonic_growth_arrest | 1.38665451 |
| 53 | MP0003119_abnormal_digestive_system | 1.38544622 |
| 54 | MP0001958_emphysema | 1.36947823 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.35455997 |
| 56 | MP0004272_abnormal_basement_membrane | 1.33162637 |
| 57 | MP0002092_abnormal_eye_morphology | 1.31433670 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.30985210 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.29585824 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.29295295 |
| 61 | MP0006082_CNS_inflammation | 1.27958134 |
| 62 | MP0000428_abnormal_craniofacial_morphol | 1.24379954 |
| 63 | MP0003075_altered_response_to | 1.23882193 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.23330215 |
| 65 | MP0002932_abnormal_joint_morphology | 1.22931641 |
| 66 | MP0000678_abnormal_parathyroid_gland | 1.22502075 |
| 67 | MP0001697_abnormal_embryo_size | 1.21990554 |
| 68 | MP0002896_abnormal_bone_mineralization | 1.19015691 |
| 69 | MP0001216_abnormal_epidermal_layer | 1.18991718 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.17797231 |
| 71 | MP0001293_anophthalmia | 1.17485425 |
| 72 | MP0003950_abnormal_plasma_membrane | 1.16963366 |
| 73 | MP0005248_abnormal_Harderian_gland | 1.15489073 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.14280603 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.13431359 |
| 76 | MP0003077_abnormal_cell_cycle | 1.12034301 |
| 77 | MP0000750_abnormal_muscle_regeneration | 1.10831769 |
| 78 | MP0003091_abnormal_cell_migration | 1.10650575 |
| 79 | MP0008770_decreased_survivor_rate | 1.09985093 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 1.09713746 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.07983276 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 1.07768053 |
| 83 | MP0009278_abnormal_bone_marrow | 1.07576181 |
| 84 | MP0002080_prenatal_lethality | 1.07529130 |
| 85 | MP0000762_abnormal_tongue_morphology | 1.06602556 |
| 86 | MP0002233_abnormal_nose_morphology | 1.06341609 |
| 87 | MP0002127_abnormal_cardiovascular_syste | 1.04495385 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.03187138 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.02816393 |
| 90 | MP0000432_abnormal_head_morphology | 1.01910259 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.01373724 |
| 92 | MP0002796_impaired_skin_barrier | 1.00607469 |
| 93 | MP0003329_amyloid_beta_deposits | 1.00419411 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.98147004 |
| 95 | MP0000604_amyloidosis | 0.97264480 |
| 96 | MP0003111_abnormal_nucleus_morphology | 0.96805958 |
| 97 | MP0003938_abnormal_ear_development | 0.96560113 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.95635380 |
| 99 | MP0003935_abnormal_craniofacial_develop | 0.95572267 |
| 100 | MP0005164_abnormal_response_to | 0.95241775 |
| 101 | MP0005165_increased_susceptibility_to | 0.93953738 |
| 102 | MP0005621_abnormal_cell_physiology | 0.93288659 |
| 103 | MP0006054_spinal_hemorrhage | 0.91336668 |
| 104 | MP0000343_altered_response_to | 0.90829482 |
| 105 | MP0003448_altered_tumor_morphology | 0.90769465 |
| 106 | MP0005025_abnormal_response_to | 0.90610112 |
| 107 | MP0000733_abnormal_muscle_development | 0.90405573 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.90071990 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.89902800 |
| 110 | MP0000685_abnormal_immune_system | 0.89809869 |
| 111 | MP0004133_heterotaxia | 0.88996621 |
| 112 | MP0000490_abnormal_crypts_of | 0.88705658 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.88636045 |
| 114 | MP0005390_skeleton_phenotype | 0.88618104 |
| 115 | MP0003755_abnormal_palate_morphology | 0.88551874 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.87602367 |
| 117 | MP0009785_altered_susceptibility_to | 0.87483782 |
| 118 | MP0005508_abnormal_skeleton_morphology | 0.87423467 |
| 119 | MP0002419_abnormal_innate_immunity | 0.87396934 |
| 120 | MP0001915_intracranial_hemorrhage | 0.86896830 |
| 121 | MP0001835_abnormal_antigen_presentation | 0.86545731 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.85733854 |
| 123 | MP0002139_abnormal_hepatobiliary_system | 0.85217299 |
| 124 | MP0002114_abnormal_axial_skeleton | 0.84590129 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.84035928 |
| 126 | MP0009703_decreased_birth_body | 0.83238294 |
| 127 | MP0001790_abnormal_immune_system | 0.82762044 |
| 128 | MP0005387_immune_system_phenotype | 0.82762044 |
| 129 | MP0001243_abnormal_dermal_layer | 0.81888507 |
| 130 | MP0000627_abnormal_mammary_gland | 0.81604377 |
| 131 | MP0002970_abnormal_white_adipose | 0.81073433 |
| 132 | MP0003300_gastrointestinal_ulcer | 0.79847443 |
| 133 | MP0010307_abnormal_tumor_latency | 0.79827526 |
| 134 | MP0001853_heart_inflammation | 0.77481117 |
| 135 | MP0005266_abnormal_metabolism | 0.76736546 |
| 136 | MP0001873_stomach_inflammation | 0.75970484 |
| 137 | MP0008004_abnormal_stomach_pH | 0.75818815 |
| 138 | MP0002269_muscular_atrophy | 0.75783993 |
| 139 | MP0009931_abnormal_skin_appearance | 0.75751673 |
| 140 | MP0005275_abnormal_skin_tensile | 0.75672911 |
| 141 | MP0001542_abnormal_bone_strength | 0.75074435 |
| 142 | MP0000858_altered_metastatic_potential | 0.74612326 |
| 143 | MP0005464_abnormal_platelet_physiology | 0.74609476 |
| 144 | MP0000313_abnormal_cell_death | 0.73665892 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.73168654 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.72972233 |
| 147 | MP0003795_abnormal_bone_structure | 0.72655265 |
| 148 | MP0000467_abnormal_esophagus_morphology | 0.72488227 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.72483134 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.69770580 |
| 151 | MP0000377_abnormal_hair_follicle | 0.69362676 |
| 152 | MP0002111_abnormal_tail_morphology | 0.69092704 |
| 153 | MP0009053_abnormal_anal_canal | 0.68319730 |
| 154 | MP0000049_abnormal_middle_ear | 0.68311830 |
| 155 | MP0010630_abnormal_cardiac_muscle | 0.67906029 |
| 156 | MP0005501_abnormal_skin_physiology | 0.66986761 |
| 157 | MP0002697_abnormal_eye_size | 0.66918390 |
| 158 | MP0000534_abnormal_ureter_morphology | 0.66775939 |
| 159 | MP0000516_abnormal_urinary_system | 0.66765671 |
| 160 | MP0005367_renal/urinary_system_phenotyp | 0.66765671 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.66701605 |
| 162 | MP0003942_abnormal_urinary_system | 0.66676935 |
| 163 | MP0002098_abnormal_vibrissa_morphology | 0.65871713 |
| 164 | MP0002452_abnormal_antigen_presenting | 0.64839503 |
| 165 | MP0005503_abnormal_tendon_morphology | 0.64470549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 5.63276244 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 4.68072670 |
| 3 | Multiple enchondromatosis (HP:0005701) | 4.61335008 |
| 4 | Hepatoblastoma (HP:0002884) | 4.46582965 |
| 5 | Ependymoma (HP:0002888) | 4.33846479 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 4.33631204 |
| 7 | Rib fusion (HP:0000902) | 3.70604767 |
| 8 | Fused cervical vertebrae (HP:0002949) | 3.37226359 |
| 9 | Astrocytoma (HP:0009592) | 3.37205618 |
| 10 | Abnormality of the astrocytes (HP:0100707) | 3.37205618 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.37192801 |
| 12 | Neoplasm of striated muscle (HP:0009728) | 3.28993777 |
| 13 | Hand muscle atrophy (HP:0009130) | 3.13590421 |
| 14 | Rhabdomyosarcoma (HP:0002859) | 3.11890254 |
| 15 | Increased connective tissue (HP:0009025) | 3.09500360 |
| 16 | Short humerus (HP:0005792) | 2.99053501 |
| 17 | Trismus (HP:0000211) | 2.90838665 |
| 18 | Flat acetabular roof (HP:0003180) | 2.90593476 |
| 19 | Achilles tendon contracture (HP:0001771) | 2.90256059 |
| 20 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.85422741 |
| 21 | Distal upper limb amyotrophy (HP:0007149) | 2.83802227 |
| 22 | Upper limb amyotrophy (HP:0009129) | 2.83802227 |
| 23 | Abnormal cartilage morphology (HP:0002763) | 2.79089065 |
| 24 | Thin bony cortex (HP:0002753) | 2.76159782 |
| 25 | Hyperacusis (HP:0010780) | 2.76083090 |
| 26 | Testicular atrophy (HP:0000029) | 2.74733214 |
| 27 | Amyotrophic lateral sclerosis (HP:0007354) | 2.71078418 |
| 28 | Cervical subluxation (HP:0003308) | 2.69626060 |
| 29 | Renal duplication (HP:0000075) | 2.65568735 |
| 30 | Abnormality of the Achilles tendon (HP:0005109) | 2.65489523 |
| 31 | Arterial tortuosity (HP:0005116) | 2.63548602 |
| 32 | Vascular tortuosity (HP:0004948) | 2.59050269 |
| 33 | Difficulty running (HP:0009046) | 2.54805651 |
| 34 | Pseudobulbar signs (HP:0002200) | 2.53200523 |
| 35 | Abnormality of the salivary glands (HP:0010286) | 2.51889132 |
| 36 | Asymmetry of the thorax (HP:0001555) | 2.51329520 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50596895 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50596895 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50596895 |
| 40 | Large earlobe (HP:0009748) | 2.49198070 |
| 41 | Shawl scrotum (HP:0000049) | 2.46787409 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.45705559 |
| 43 | Osteolytic defects of the hand bones (HP:0009699) | 2.45502350 |
| 44 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45502350 |
| 45 | Abnormality of the musculature of the hand (HP:0001421) | 2.43870432 |
| 46 | Peritonitis (HP:0002586) | 2.39462352 |
| 47 | Fragile skin (HP:0001030) | 2.37480152 |
| 48 | Resting tremor (HP:0002322) | 2.37386274 |
| 49 | Atrophic scars (HP:0001075) | 2.36931300 |
| 50 | Ankle contracture (HP:0006466) | 2.36552414 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.34489975 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.33845398 |
| 53 | Preauricular skin tag (HP:0000384) | 2.33812872 |
| 54 | Broad face (HP:0000283) | 2.33154776 |
| 55 | Ulnar bowing (HP:0003031) | 2.30275685 |
| 56 | Spondylolisthesis (HP:0003302) | 2.29404281 |
| 57 | Hyperparathyroidism (HP:0000843) | 2.28361820 |
| 58 | Aortic dissection (HP:0002647) | 2.28331848 |
| 59 | Adenoma sebaceum (HP:0009720) | 2.27796503 |
| 60 | Angiofibromas (HP:0010615) | 2.27796503 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26898579 |
| 62 | Neoplasm of the heart (HP:0100544) | 2.25786810 |
| 63 | Blue sclerae (HP:0000592) | 2.24111481 |
| 64 | Hypopigmentation of the fundus (HP:0007894) | 2.23529506 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.23310157 |
| 66 | Glioma (HP:0009733) | 2.23286423 |
| 67 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.23224911 |
| 68 | Spinal rigidity (HP:0003306) | 2.23201528 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23189230 |
| 70 | Skin tags (HP:0010609) | 2.21886195 |
| 71 | Short nail (HP:0001799) | 2.21053722 |
| 72 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.19713451 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.18608826 |
| 74 | Horizontal nystagmus (HP:0000666) | 2.16316208 |
| 75 | Dilatation of the ascending aorta (HP:0005111) | 2.15919419 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.15564605 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15564605 |
| 78 | Rectal fistula (HP:0100590) | 2.15223416 |
| 79 | Rectovaginal fistula (HP:0000143) | 2.15223416 |
| 80 | Missing ribs (HP:0000921) | 2.14236672 |
| 81 | Wormian bones (HP:0002645) | 2.14047637 |
| 82 | Fasciculations (HP:0002380) | 2.13954857 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.13583588 |
| 84 | Mitral valve prolapse (HP:0001634) | 2.11982665 |
| 85 | Aortic aneurysm (HP:0004942) | 2.11788293 |
| 86 | Vertebral fusion (HP:0002948) | 2.11499562 |
| 87 | Short 5th finger (HP:0009237) | 2.11312156 |
| 88 | Abnormality of carpal bone ossification (HP:0006257) | 2.11161171 |
| 89 | Embryonal renal neoplasm (HP:0011794) | 2.09150922 |
| 90 | Loss of speech (HP:0002371) | 2.08919519 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.08574524 |
| 92 | Abnormal ossification of hand bones (HP:0005921) | 2.07514275 |
| 93 | Micronodular cirrhosis (HP:0001413) | 2.06985142 |
| 94 | Deep venous thrombosis (HP:0002625) | 2.04537297 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.03437900 |
| 96 | Generalized hypotonia (HP:0001290) | 2.03360609 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02242438 |
| 98 | Syringomyelia (HP:0003396) | 2.01165958 |
| 99 | Spinal cord lesions (HP:0100561) | 2.01165958 |
| 100 | Nuclear cataract (HP:0100018) | 2.01158261 |
| 101 | Elbow flexion contracture (HP:0002987) | 2.00794119 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99278524 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99278524 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99278524 |
| 105 | Bladder diverticulum (HP:0000015) | 1.99010780 |
| 106 | Cerebral aneurysm (HP:0004944) | 1.98636612 |
| 107 | Genu recurvatum (HP:0002816) | 1.98160198 |
| 108 | Aneurysm (HP:0002617) | 1.98044193 |
| 109 | Vaginal fistula (HP:0004320) | 1.97964691 |
| 110 | Mitral regurgitation (HP:0001653) | 1.96830333 |
| 111 | Shallow orbits (HP:0000586) | 1.95820697 |
| 112 | Lymphangioma (HP:0100764) | 1.93559390 |
| 113 | Myocardial infarction (HP:0001658) | 1.93170898 |
| 114 | Preauricular pit (HP:0004467) | 1.92785351 |
| 115 | Periauricular skin pits (HP:0100277) | 1.92785351 |
| 116 | J-shaped sella turcica (HP:0002680) | 1.92393965 |
| 117 | Intestinal fistula (HP:0100819) | 1.92302678 |
| 118 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91275352 |
| 119 | Malnutrition (HP:0004395) | 1.91015294 |
| 120 | Ankyloglossia (HP:0010296) | 1.89962352 |
| 121 | Premature rupture of membranes (HP:0001788) | 1.89948200 |
| 122 | Disproportionate tall stature (HP:0001519) | 1.89408434 |
| 123 | Spinal cord compression (HP:0002176) | 1.88411093 |
| 124 | Skin nodule (HP:0200036) | 1.88402359 |
| 125 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.87925506 |
| 126 | Villous atrophy (HP:0011473) | 1.87925506 |
| 127 | Hypochromic anemia (HP:0001931) | 1.87827823 |
| 128 | Bone pain (HP:0002653) | 1.87186306 |
| 129 | Macroorchidism (HP:0000053) | 1.86945455 |
| 130 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.86891207 |
| 131 | Abnormality of the acetabulum (HP:0003170) | 1.86436955 |
| 132 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.86216668 |
| 133 | Glossoptosis (HP:0000162) | 1.85282280 |
| 134 | Progressive muscle weakness (HP:0003323) | 1.84846358 |
| 135 | Upper motor neuron abnormality (HP:0002127) | 1.83586893 |
| 136 | Gastrointestinal carcinoma (HP:0002672) | 1.82985349 |
| 137 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.82985349 |
| 138 | Natal tooth (HP:0000695) | 1.82817355 |
| 139 | Insomnia (HP:0100785) | 1.82510062 |
| 140 | Cupped ribs (HP:0000887) | 1.82023834 |
| 141 | Radial bowing (HP:0002986) | 1.80199907 |
| 142 | Coxa vara (HP:0002812) | 1.78947270 |
| 143 | Muscle fibrillation (HP:0010546) | 1.78869666 |
| 144 | Tetraplegia (HP:0002445) | 1.78009424 |
| 145 | Fibroma (HP:0010614) | 1.77937558 |
| 146 | Esophageal varix (HP:0002040) | 1.77693162 |
| 147 | Biconcave vertebral bodies (HP:0004586) | 1.77657464 |
| 148 | Partial duplication of thumb phalanx (HP:0009944) | 1.76577309 |
| 149 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.76334313 |
| 150 | Long palpebral fissure (HP:0000637) | 1.76180789 |
| 151 | Axonal loss (HP:0003447) | 1.76001764 |
| 152 | Selective tooth agenesis (HP:0001592) | 1.75244178 |
| 153 | Broad thumb (HP:0011304) | 1.74873613 |
| 154 | Abnormality of the thoracic spine (HP:0100711) | 1.74565507 |
| 155 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.74440743 |
| 156 | Bifid tongue (HP:0010297) | 1.73607370 |
| 157 | Abnormality of oral frenula (HP:0000190) | 1.73145669 |
| 158 | Skin pits (HP:0100276) | 1.72958190 |
| 159 | Abnormality of chromosome segregation (HP:0002916) | 1.72797256 |
| 160 | Renal cell carcinoma (HP:0005584) | 1.72763838 |
| 161 | Emphysema (HP:0002097) | 1.72608255 |
| 162 | Partial duplication of the phalanx of hand (HP:0009999) | 1.71995112 |
| 163 | Advanced eruption of teeth (HP:0006288) | 1.71331470 |
| 164 | Uterine leiomyosarcoma (HP:0002891) | 1.70027172 |
| 165 | Leiomyosarcoma (HP:0100243) | 1.70027172 |
| 166 | Broad palm (HP:0001169) | 1.69946077 |
| 167 | Broad metatarsal (HP:0001783) | 1.69911179 |
| 168 | Spinal muscular atrophy (HP:0007269) | 1.69285508 |
| 169 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.66321888 |
| 170 | Obstructive sleep apnea (HP:0002870) | 1.65779689 |
| 171 | Increased cerebral lipofuscin (HP:0011813) | 1.65749438 |
| 172 | Long toe (HP:0010511) | 1.65495172 |
| 173 | Joint laxity (HP:0001388) | 1.63909679 |
| 174 | Generalized amyotrophy (HP:0003700) | 1.63198200 |
| 175 | Polygenic inheritance (HP:0010982) | 1.61354829 |
| 176 | Sparse lateral eyebrow (HP:0005338) | 1.61144588 |
| 177 | Congenital glaucoma (HP:0001087) | 1.59709517 |
| 178 | Absent frontal sinuses (HP:0002688) | 1.58994817 |
| 179 | Abnormality of macrophages (HP:0004311) | 1.57315516 |
| 180 | Abnormality of dentin (HP:0010299) | 1.56694951 |
| 181 | Stridor (HP:0010307) | 1.55745867 |
| 182 | Back pain (HP:0003418) | 1.55322997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.77855279 |
| 2 | ERN1 | 4.39547464 |
| 3 | GRK5 | 3.52595207 |
| 4 | IRAK3 | 3.49099497 |
| 5 | GRK6 | 3.29269156 |
| 6 | PRPF4B | 3.04330421 |
| 7 | NME2 | 2.70679765 |
| 8 | SMG1 | 2.68664767 |
| 9 | TRIB3 | 2.66133722 |
| 10 | TYRO3 | 2.60476481 |
| 11 | FGFR4 | 2.27665988 |
| 12 | TGFBR2 | 2.11383604 |
| 13 | STK10 | 2.08155639 |
| 14 | CSF1R | 2.02842056 |
| 15 | EPHA2 | 1.92611520 |
| 16 | MATK | 1.92563177 |
| 17 | TTK | 1.92312083 |
| 18 | MAP3K10 | 1.78144778 |
| 19 | MST1R | 1.78046585 |
| 20 | PKN2 | 1.73995158 |
| 21 | LATS2 | 1.71155225 |
| 22 | TAOK2 | 1.70568767 |
| 23 | MOS | 1.64199898 |
| 24 | PAK4 | 1.61388826 |
| 25 | MAP3K14 | 1.56900637 |
| 26 | GRK1 | 1.56397957 |
| 27 | NTRK1 | 1.54313977 |
| 28 | PDGFRA | 1.51638506 |
| 29 | ALK | 1.48353853 |
| 30 | TESK1 | 1.46737630 |
| 31 | RIPK1 | 1.39454000 |
| 32 | EPHB1 | 1.36428887 |
| 33 | MAP3K9 | 1.33792285 |
| 34 | WNK1 | 1.33722415 |
| 35 | PRKG2 | 1.29198962 |
| 36 | SCYL2 | 1.28536597 |
| 37 | MAPK7 | 1.25379081 |
| 38 | CDC42BPA | 1.25223041 |
| 39 | DDR2 | 1.23556794 |
| 40 | EEF2K | 1.20134547 |
| 41 | BMX | 1.19487171 |
| 42 | CDK7 | 1.17676952 |
| 43 | ADRBK2 | 1.17356552 |
| 44 | LATS1 | 1.17277829 |
| 45 | TBK1 | 1.15981431 |
| 46 | MAP3K13 | 1.15345089 |
| 47 | TYK2 | 1.15145041 |
| 48 | FGFR3 | 1.04189430 |
| 49 | PTK2 | 1.03735529 |
| 50 | MTOR | 1.00734842 |
| 51 | TTN | 0.99888618 |
| 52 | LMTK2 | 0.98774754 |
| 53 | SIK3 | 0.97235477 |
| 54 | GRK7 | 0.95011354 |
| 55 | CAMK4 | 0.92856922 |
| 56 | NEK2 | 0.90978220 |
| 57 | RPS6KB2 | 0.90044762 |
| 58 | MAP2K4 | 0.88119670 |
| 59 | MAP3K3 | 0.87480505 |
| 60 | NEK1 | 0.85840816 |
| 61 | PIM2 | 0.85493487 |
| 62 | KSR2 | 0.84100759 |
| 63 | MAP3K7 | 0.82093173 |
| 64 | MAP3K1 | 0.80826169 |
| 65 | TESK2 | 0.80686365 |
| 66 | HIPK2 | 0.80564843 |
| 67 | JAK3 | 0.79477229 |
| 68 | NEK9 | 0.79053419 |
| 69 | MARK2 | 0.78887949 |
| 70 | JAK1 | 0.78734546 |
| 71 | CSK | 0.77885369 |
| 72 | PDPK1 | 0.76779163 |
| 73 | RPS6KA2 | 0.76274313 |
| 74 | ICK | 0.75401258 |
| 75 | SIK1 | 0.74498055 |
| 76 | CHEK2 | 0.73587576 |
| 77 | PTK6 | 0.72485514 |
| 78 | PLK1 | 0.71327266 |
| 79 | CHUK | 0.69462373 |
| 80 | PAK2 | 0.67990258 |
| 81 | MAP2K3 | 0.67247745 |
| 82 | TAOK1 | 0.65989432 |
| 83 | ZAP70 | 0.65520597 |
| 84 | ARAF | 0.65322122 |
| 85 | AKT2 | 0.64853585 |
| 86 | LRRK2 | 0.63212217 |
| 87 | CHEK1 | 0.62236575 |
| 88 | CDK4 | 0.61611681 |
| 89 | CDC7 | 0.60904338 |
| 90 | ADRBK1 | 0.60116607 |
| 91 | MET | 0.55381909 |
| 92 | IRAK4 | 0.55358745 |
| 93 | MAPK11 | 0.53987412 |
| 94 | TRPM7 | 0.53516995 |
| 95 | ERBB4 | 0.52878233 |
| 96 | MAP3K6 | 0.51445335 |
| 97 | MAP3K8 | 0.51079838 |
| 98 | MAP3K11 | 0.48027963 |
| 99 | RPS6KC1 | 0.47135570 |
| 100 | RPS6KL1 | 0.47135570 |
| 101 | PRKCI | 0.46485955 |
| 102 | ILK | 0.46043960 |
| 103 | IKBKE | 0.44750380 |
| 104 | DMPK | 0.43785950 |
| 105 | CDK6 | 0.43289131 |
| 106 | CDK2 | 0.42999781 |
| 107 | CLK1 | 0.42935701 |
| 108 | CAMK1D | 0.42723287 |
| 109 | STK3 | 0.42496964 |
| 110 | PAK6 | 0.42208644 |
| 111 | PAK3 | 0.42030255 |
| 112 | STK38 | 0.41752080 |
| 113 | PRKD2 | 0.41716094 |
| 114 | EPHB2 | 0.40967823 |
| 115 | LIMK1 | 0.40868345 |
| 116 | FGR | 0.40812648 |
| 117 | FLT3 | 0.40763047 |
| 118 | CDK9 | 0.40512267 |
| 119 | PAK1 | 0.39475289 |
| 120 | SGK3 | 0.39419895 |
| 121 | ROCK2 | 0.39418370 |
| 122 | PDGFRB | 0.39384210 |
| 123 | CSNK1E | 0.39238822 |
| 124 | GSK3A | 0.38906613 |
| 125 | RET | 0.38818020 |
| 126 | RIPK4 | 0.38640896 |
| 127 | MAPKAPK3 | 0.38243890 |
| 128 | IRAK2 | 0.36948950 |
| 129 | FER | 0.35537836 |
| 130 | ERBB2 | 0.35496857 |
| 131 | EGFR | 0.34917839 |
| 132 | MAP3K2 | 0.34579033 |
| 133 | INSR | 0.33027839 |
| 134 | MAP2K6 | 0.32010492 |
| 135 | DYRK1B | 0.27436103 |
| 136 | MAPK1 | 0.25292590 |
| 137 | IGF1R | 0.24907876 |
| 138 | AURKA | 0.24499398 |
| 139 | MAP2K2 | 0.23869043 |
| 140 | MAPK10 | 0.23000800 |
| 141 | MAPK12 | 0.22604532 |
| 142 | PRKCH | 0.22345561 |
| 143 | AURKB | 0.22117105 |
| 144 | PRKD3 | 0.20047569 |
| 145 | ATM | 0.19939309 |
| 146 | MELK | 0.19425082 |
| 147 | AKT3 | 0.18361984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.19605329 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.11903542 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.77633245 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.58574797 |
| 5 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.41051562 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38924187 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.20926486 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09751478 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80957565 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 1.79698077 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75756712 |
| 12 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.66221678 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.65475086 |
| 14 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.58613993 |
| 15 | Hepatitis C_Homo sapiens_hsa05160 | 1.53325480 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52891516 |
| 17 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.48636097 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.46788800 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.43321217 |
| 20 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.42949736 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42937214 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.38734119 |
| 23 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.38568255 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.38116319 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34782012 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30847699 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28398326 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23397478 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.22635529 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22265040 |
| 31 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.22109390 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.21371325 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20782667 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.20081216 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.19650050 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18927354 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18883502 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18308517 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16393037 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12790226 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11780133 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10394180 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09530533 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.08753883 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.07873120 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06314044 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05806993 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01372202 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.00910675 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 1.00862449 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00852315 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99115700 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.98951130 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98745815 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98373779 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97605866 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 0.97457544 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96905254 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96833442 |
| 60 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.96725849 |
| 61 | Pathways in cancer_Homo sapiens_hsa05200 | 0.96092325 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95278093 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.95016435 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94414046 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93715319 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93024575 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.92838524 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92321023 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91499313 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90823395 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90713705 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89945787 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89783475 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89713127 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86548553 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84361397 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84182746 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83937453 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83795932 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.83397912 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82783605 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82658889 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82451944 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.82268266 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81314748 |
| 86 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79103798 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78660536 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.78290685 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77090412 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.75542521 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.74665505 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73331178 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73010543 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72815528 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72191484 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72019901 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71418063 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70946317 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70126185 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69820345 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68811182 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68761549 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68603370 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.67914740 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67772633 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66552527 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65444419 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64562908 |
| 109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64491031 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63592584 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62747907 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61145774 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60082213 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59829004 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59182092 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58857826 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58695519 |
| 118 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57285588 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55590293 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55211976 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54573133 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54207187 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.53997710 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52218216 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51283751 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51239940 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51087442 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.50603189 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50321028 |
| 130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50169652 |
| 131 | Lysine degradation_Homo sapiens_hsa00310 | 0.50035369 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49768999 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49662632 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49569271 |
| 135 | Legionellosis_Homo sapiens_hsa05134 | 0.48796231 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47182941 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45721838 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45688284 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.45453324 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44960085 |

